CA2347336A1 - A1 adenosine receptor agonists - Google Patents

A1 adenosine receptor agonists

Info

Publication number
CA2347336A1
CA2347336A1 CA002347336A CA2347336A CA2347336A1 CA 2347336 A1 CA2347336 A1 CA 2347336A1 CA 002347336 A CA002347336 A CA 002347336A CA 2347336 A CA2347336 A CA 2347336A CA 2347336 A1 CA2347336 A1 CA 2347336A1
Authority
CA
Canada
Prior art keywords
receptor agonists
adenosine receptor
formula
adenosine
see formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002347336A
Other languages
French (fr)
Other versions
CA2347336C (en
Inventor
Luiz Belardinelli
Ray Olsson
Stephen Baker
Peter J. Scammells
Peter Gerard Milner
Jurg Roland Pfister
George Frederic Schreiner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Florida Research Foundation Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/144,459 external-priority patent/US5446046A/en
Application filed by Individual filed Critical Individual
Publication of CA2347336A1 publication Critical patent/CA2347336A1/en
Application granted granted Critical
Publication of CA2347336C publication Critical patent/CA2347336C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

An N6 adenosine compound of the formula:
(See Formula I) wherein R = (See Formula II or III) and R1 an alkyl group having 1-4 carbon atoms. Compounds according to the invention are A1 adenosine receptor agonists and may therefore be used as .beta.-blockers and antiarrhythmic agents.
CA002347336A 1993-10-28 1994-10-28 A1 adenosine receptor agonists Expired - Fee Related CA2347336C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/144,459 US5446046A (en) 1993-10-28 1993-10-28 A1 adenosine receptor agonists and antagonists as diuretics
US144,459 1993-10-28
CA002172726A CA2172726C (en) 1993-10-28 1994-10-28 A1 adenosine receptor antagonists

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CA002172726A Division CA2172726C (en) 1993-10-28 1994-10-28 A1 adenosine receptor antagonists

Publications (2)

Publication Number Publication Date
CA2347336A1 true CA2347336A1 (en) 1995-05-04
CA2347336C CA2347336C (en) 2004-08-24

Family

ID=25678393

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002347336A Expired - Fee Related CA2347336C (en) 1993-10-28 1994-10-28 A1 adenosine receptor agonists

Country Status (1)

Country Link
CA (1) CA2347336C (en)

Also Published As

Publication number Publication date
CA2347336C (en) 2004-08-24

Similar Documents

Publication Publication Date Title
CA2103861A1 (en) Novel 7-(substituted)-8-(substituted-9-(substituted amino)-6-demethyl-6-deoxytetracyclines
CA2502856A1 (en) Intermediates for retroviral protease inhibiting compounds
CA2103845A1 (en) 9-[(substituted glycyl)-amido]-6-demethyl-6-deoxytetracyclines
WO1995007918A3 (en) Pyrimidine derivatives for labeled binding partners
CA2159988A1 (en) Novel deoxygalactonojirimycin derivatives
CA2120374A1 (en) 9-[(substituted glycyl) amido]-6-(substituted)-5-hydroxy-6-deoxytetracyclines
CA2160137A1 (en) Bicyclic Ansamycins
SG47559A1 (en) 7-(substituted)-9-[(substituted glycl) amido]-6-demethyl-6-deoxytetracyclines
WO1999024450A3 (en) Adensine a1 receptor agonists
AU4237793A (en) Alkyl glycoside compositions with improved wetting properties
IL103301A0 (en) Pyrimidine nucleoside derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
UA70991C2 (en) N2-phenylamidine derivatives, application thereof and intermediary compounds
CA2110693A1 (en) Amino acid derivative anticonvulsant
WO1999024449A3 (en) Adenosine a1 receptor agonists
NZ290721A (en) Process for making quinolone-containing antimicrobial compounds
MY123083A (en) Acyclic nucleoside derivatives
ES8705412A1 (en) Furan derivatives having anti-ulcer activity.
CA2010035A1 (en) Proline derivatives
CA2036228A1 (en) Industrial antifungal composition
CA2347336A1 (en) A1 adenosine receptor agonists
MY103393A (en) 4-oxo-3-quinolinecarboxylic acids useful as antibacterial agents and preparation thereof
CA2146322A1 (en) Oleaginous compositions
CA2025858A1 (en) Antihepatopathic composition
ES8505684A1 (en) 5-Substituted(1,2,4)triazolo(1,5-c)pyrimidin-2-amines.
GR3029590T3 (en) Crystalline, polymorphic form of (s,s,s)-n-(1- 2-carboxy-3-(n?2 -mesyllysylamino)propyl]-1-cyclopentylcarbonyl)tyrosine

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed

Effective date: 20131029